Skip to Content

Johnson & Johnson

JNJ: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$542.00VzhHxfmlgpd

Johnson & Johnson: Kenvue IPO Raises $4 Billion, Setting the Stage for Full Divestment Later in 2023

Johnson and Johnson raised close to $4 billion by selling almost 10% of its consumer business called Kenvue through an initial public offering. We expect J&J will divest the remaining Kenvue portion later in the year likely through a spinoff or split off. The implied valuation of close to $40 billion for Kenvue represents slightly lower valuation multiples than similar companies, but we don’t expect any major fair value estimate changes to J&J based on the initial partial sale of the unit.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of JNJ so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center